Drug Delivery & Targeting Group, Molecular Biology & Biochemistry Research Centre for Nanomedicine (CIBBIM-Nanomedicine), Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Networking Research Centre for Bioengineering, Biomaterials & Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Nanomedicine (Lond). 2020 Dec;15(28):2785-2800. doi: 10.2217/nnm-2020-0099. Epub 2020 Nov 16.
The presence of highly resistant cancer stem cells (CSCs) within tumors as drivers of metastatic spread has been commonly accepted. Nonetheless, the likelihood of its dynamic phenotype has been strongly discussed. Importantly, intratumoral cell-to-cell communication seems to act as the main regulatory mechanism of CSC reversion. Today, new strategies for cancer treatment focusing into modulating tumor cell intercommunication and the possibility to modulate the composition of the tumor microenvironment are being explored. In this review, we summarize the literature describing the phenomenon of CSC reversion and the factors known to influence this phenotypic switch. Furthermore, we will discuss the possible role of nanomedicine toward altering this reversion, and to influence the tumor microenvironment composition and the metastatic spread of the disease.
肿瘤内高度耐药的癌症干细胞(CSC)作为转移扩散的驱动因素已被普遍接受。然而,其动态表型的可能性仍存在激烈争议。重要的是,肿瘤内细胞间的通讯似乎是 CSC 逆转的主要调节机制。目前,新的癌症治疗策略侧重于调节肿瘤细胞间的通讯,并探索调节肿瘤微环境组成的可能性。在这篇综述中,我们总结了描述 CSC 逆转现象以及已知影响这种表型转变的因素的文献。此外,我们还将讨论纳米医学在改变这种逆转以及影响肿瘤微环境组成和疾病转移扩散方面的可能作用。